I am truly thankful to our users who collaborate with us on a daily basis, providing their advisory guidance on the evolving landscape of chemistry-driven industries; and to my colleagues, and our collaborators, who take these ideas and suggestions and embody them into useful practical software applications! Wishing all of you strong health and success in 2022!
The pharmaceutical industry has renewed its interest in HTE these last few years. Leaders see it as a way to get medicines to patients faster, but they’re also attracted by the sheer quantity of data generated in parallel experiments. How and where should HTE be set up for maximum success? Read this blog for questions that should be considered.
For scientists involved in pharmaceutical development, high throughput experimentation is commonplace for activities such as reaction optimization, process development, catalyst screening, and reaction scale-up. While there are many observed benefits of implementing HTE workflows in laboratories, it also dramatically affects corporate informatics infrastructures and there are significant impediments to its utilization. In order to optimize laboratory efficiency and support the lab of the future, the industry requires a technological solution that can help streamline workflows and demonstrate data integrity. That's why we've recently launched Katalyst D2D to solve the industry’s greatest pain points in HT experimentation. Read on to learn more about our new solution for high throughput experimentation and parallel synthesis.